Postconization Surveillance of Cervical Adenocarcinoma in Situ: A Prospective Trial

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 48, Issue 10, 2003, Pages 751-755

  Schorge, John O ^a   Lea, Jayanthi S ^b   Ashfaq, Raheela ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b NONE

Author keywords

Adenocarcinoma; Cervical cancer; Post conization surveillance

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONSERVATIVE TREATMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CURETTAGE; FEMALE; FEMALE FERTILITY; FOLLOW UP; HEALTH SURVEY; HUMAN; NULLIPARA; PAPANICOLAOU TEST; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; TREATMENT OUTCOME; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CONIZATION;

ADENOCARCINOMA; ADULT; CARCINOMA IN SITU; CONIZATION; FEMALE; FERTILITY; HUMANS; NEOPLASM RECURRENCE, LOCAL; POSTOPERATIVE PERIOD; PROSPECTIVE STUDIES; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 0142182626     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Smith HO, Tiffany MF, Qualls CR, et al: The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the U.S.: A 24-year population-based study. Gynecol Oncol 2000;78:97-105
2. Plaxe SC, Saltzstein SL: Estimation of the duration of the pre-clinical phase of cervical adenocarcinoma suggests that there is ample opportunity for screening. Gynecol Oncol 1999;75:55-61
3. Lee KR, Flynn CE: Early invasive adenocarcinoma of the cervix: A histopathologic analysis of 40 cases with observations concerning histogenesis. Cancer 2000;89:1048-1055
4. Hopkins MP, Roberts JA, Schmidt RW: Cervical adenocarcinoma in situ. Obstet Gynecol 1988;71:842-844
5. McHale MT, Le TD, Burger RA, et al: Fertility sparing treatment for in situ and early invasive adenocarcinoma of the cervix. Obstet Gynecol 2001;98:726-731
6. Andersen ES, Neilsen K: Adenocarcinoma in situ of the cervix: A prospective study of conization as definitive treatment. Gynecol Oncol 2002;86:365-369
7. Shin CH, Schorge JO, Lee KR, et al: Conservative management of adenocarcinoma in situ of the cervix. Gynecol Oncol 2000;79:6-10
8. Ostor A, Duncan A, Quinn M, et al: Adenocarcinoma in situ of the uterine cervix: An experience with 100 cases. Gynecol Oncol 2000;79:207-210
9. Muntz HG: Can cervical adenocarcinoma in situ be safely managed by conization alone? Gynecol Oncol 1996;61:301-303
10. Hopkins MP: Adenocarcinoma in situ of the cervix: The margins must be clear. Gynecol Oncol 2000;79:4-5
11. Soutter WP, Haidopoulos D, Gornall RJ, et al: Is conservative treatment for adenocarcinoma in situ of the cervix safe? Br J Obstet Gynaecol 2001;108:1184-1189
12. Bertrand M, Lickrish GM, Colgan TJ: The anatomic distribution of cervical adenocarcinoma in situ: Implications for treatment. Am J Obstet Gynecol 1987;157:21-25
13. Shin CH, Schorge JO, Lee KR, et al: Cytologic and biopsy findings leading to conization in adenocarcinoma in situ of the cervix. Obstet Gynecol 2002;100:271-276
14. Kennedy AW, Biscotti CV: Further study of the management of cervical adenocarcinoma in situ. Gynecol Oncol 2002;86:361-364
15. Wright TC Jr, Cox JT, Massad LS, et al: 2001 Consensus guidelines for the management of women with cervical cytological abnormalities. JAMA 2002;287:2120-2129
16. Lea JS, Shin CH, Sheets EE, et al: Endocervical curettage at conization to predict residual cervical adenocarcinoma in situ. Gynecol Oncol 2002;87:129-132
17. Andersen ES, Arffmann E: Adenocarcinoma in situ of the uterine cervix: A clinicopathologic study of 36 cases. Gynecol Oncol 1989;35:1-7
18. Cullimore JE, Luesley DM, Rollason TP, et al: A prospective study of conization of the cervix in the management of cervical intraepithelial glandular neoplasia (CIGN): A preliminary report. Br J Obstet Gynaecol 1992;99:314-318
19. Etherington IJ, Luesley DM: Adenocarcinoma in situ of the cervix: Controversies in diagnosis and treatment. J Lower Gen Tract Dis 2001;5:94-98
20. Im DD, Duska LR, Rosenshein NB: Adequacy of conization margins in adenocarcinoma in situ of the cervix as a predictor of residual disease. Gynecol Oncol 1995;59:179-182
21. Denehy TR, Gregori CA, Breen JL: Endocervical curettage, cone margins, and residual adenocarcinoma in situ of the cervix. Obstet Gynecol 1997;90:1-6
22. Poynor EA, Barakat RR, Hoskins WJ: Management and follow-up of patients with adenocarcinoma in situ of the uterine cervix. Gynecol Oncol 1995;57:158-164
23. Azodi M, Chambers SK, Rutherford TJ, et al: Adenocarcinoma in situ of the cervix: Management and outcome. Gynecol Oncol 1999;73:348-353
24. Wolf JK, Levenback C, Malpica A, et al: Adenocarcinoma in situ of the cervix: Significance of cone biopsy margins. Obstet Gynecol 1996;88:82-86